Cutting Edge: TLR2 Signaling in B Cells Promotes Autoreactivity to DNA via IL-6 Secretion.
Chetna SoniSohei MakitaAnna EichingerLee SerpasVanja SisirakBoris ReizisPublished in: Journal of immunology (Baltimore, Md. : 1950) (2023)
Autoantibodies to chromatin and dsDNA are a hallmark of systemic lupus erythematosus (SLE). In a mouse model of monogenic human SLE caused by DNASE1L3 deficiency, the anti-DNA response is dependent on endosomal nucleic acid-sensing TLRs TLR7 and TLR9. In this study, we report that this response also required TLR2, a surface receptor for microbial products that is primarily expressed on myeloid cells. Cell transfers into lymphopenic DNASE1L3-deficient mice showed that TLR2 was required for anti-DNA Ab production by lymphocytes. TLR2 was detectably expressed on B cells and facilitated the production of IL-6 by B cells activated in the presence of microbial products. Accordingly, treatment with broad-spectrum antibiotics or Ab-mediated blockade of IL-6 delayed the anti-DNA response in DNASE1L3-deficient mice. These studies reveal an unexpected B cell-intrinsic role of TLR2 in systemic autoreactivity to DNA, and they suggest that microbial products may synergize with self-DNA in the activation of autoreactive B cells in SLE.
Keyphrases
- systemic lupus erythematosus
- nucleic acid
- toll like receptor
- circulating tumor
- inflammatory response
- cell free
- immune response
- single molecule
- disease activity
- mouse model
- nuclear factor
- microbial community
- gene expression
- endothelial cells
- single cell
- oxidative stress
- dendritic cells
- bone marrow
- cell death
- circulating tumor cells
- transcription factor
- dna methylation
- cell proliferation
- acute myeloid leukemia
- rheumatoid arthritis
- binding protein
- cell therapy
- case control
- pi k akt